STAR 20189

Trial Information

A Phase 3 Global, Multicenter, Double-Blind Randomized Study of Carboplatin-Paclitaxel With INCMGA00012 or Placebo in Participants With Inoperable Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Anal Canal Not Previously Treated With Systemic Chemotherapy (POD1UM-303/InterAACT 2) (INCMGA 0012-303)

Quality Care Close to Home


View our locations on map!

Sign Up Today For Our E-Newsletter

United in Healing with The US Oncology Network - Maryland Oncology Hematology